Korea Joongang Daily
Korea JoongAng Daily

Huons Global's Q3 profits soar

Huons Global saw an on-year surge in its Q3 operating profits, driven by strong growth from subsidiaries Huons, Humedix, and HuM&C.

2023-11-14

Huons post record $27M profit on strong U.S. drug sales

Huons Global posted a 77.2-percent on-year surge in operating profit to a record of 36.5 billion won ($27.3 million) in the second quarter, partly driven by strong drug sales in the United States.

2023-08-16

Huons Global hires outsider to be its first president

Huons Global has appointed 58-year-old Song Soo-young as president, the biopharmaceutical company said Thursday.

2022-02-03

ESG award

Yoon Sung-tae, vice chairman of Huons Global, front left, is awarded a commendation from the Ministry of Trade, Industry and Energy on Wednesday in acknowledgement of the company’s environmental, social and governance (ESG) management efforts...

2021-12-03

Korean pharmaceutical companies build business at CPhI

MILAN, Italy — Crowds were wanting at the Korea Pavilion at the Convention on Pharmaceutical Ingredients (CPhI) Worldwide 2021. Enthusiasm was anything but.

2021-11-11

Huons BioPharma signs big Hutox deal with Germany's Haemato Pharm

Huons BioPharma signed a deal potentially worth 97.2 billion won ($83.4 million) with Berlin, Germany’s Haemato Pharm to supply its Hutox botulinum toxin for sale in the European market.

2021-10-26